244 related articles for article (PubMed ID: 11713370)
1. Synthetic phosphoantigens enhance human Vgamma9Vdelta2 T lymphocytes killing of non-Hodgkin's B lymphoma.
Sicard H; Al Saati T; Delsol G; Fournié JJ
Mol Med; 2001 Oct; 7(10):711-22. PubMed ID: 11713370
[TBL] [Abstract][Full Text] [Related]
2. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive V gamma 9V delta 2 T lymphocytes.
Poccia F; Cipriani B; Vendetti S; Colizzi V; Poquet Y; Battistini L; López-Botet M; Fournié JJ; Gougeon ML
J Immunol; 1997 Dec; 159(12):6009-17. PubMed ID: 9550399
[TBL] [Abstract][Full Text] [Related]
3. Vgamma9Vdelta2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas.
Bouet-Toussaint F; Cabillic F; Toutirais O; Le Gallo M; Thomas de la Pintière C; Daniel P; Genetet N; Meunier B; Dupont-Bierre E; Boudjema K; Catros V
Cancer Immunol Immunother; 2008 Apr; 57(4):531-9. PubMed ID: 17764010
[TBL] [Abstract][Full Text] [Related]
4. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells.
Toutirais O; Cabillic F; Le Friec G; Salot S; Loyer P; Le Gallo M; Desille M; de La Pintière CT; Daniel P; Bouet F; Catros V
Eur J Immunol; 2009 May; 39(5):1361-8. PubMed ID: 19404979
[TBL] [Abstract][Full Text] [Related]
5. Phosphostim-activated gamma delta T cells kill autologous metastatic renal cell carcinoma.
Viey E; Fromont G; Escudier B; Morel Y; Da Rocha S; Chouaib S; Caignard A
J Immunol; 2005 Feb; 174(3):1338-47. PubMed ID: 15661891
[TBL] [Abstract][Full Text] [Related]
6. Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells.
Gomes AQ; Correia DV; Grosso AR; Lança T; Ferreira C; Lacerda JF; Barata JT; Silva MG; Silva-Santos B
Haematologica; 2010 Aug; 95(8):1397-404. PubMed ID: 20220060
[TBL] [Abstract][Full Text] [Related]
7. In vivo gammadelta T cell priming to mycobacterial antigens by primary Mycobacterium tuberculosis infection and exposure to nonpeptidic ligands.
Poccia F; Malkovsky M; Pollak A; Colizzi V; Sireci G; Salerno A; Dieli F
Mol Med; 1999 Jul; 5(7):471-6. PubMed ID: 10449808
[TBL] [Abstract][Full Text] [Related]
8. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
[TBL] [Abstract][Full Text] [Related]
9. From the study of tumor cell immunogenicity to the generation of antitumor cytotoxic cells in non-Hodgkin's lymphomas.
Chaperot L; Jacob MC; Molens JP; Manches O; Bensa JC; Plumas J
Leuk Lymphoma; 2000 Jul; 38(3-4):247-63. PubMed ID: 10830732
[TBL] [Abstract][Full Text] [Related]
10. In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model.
Sicard H; Ingoure S; Luciani B; Serraz C; Fournié JJ; Bonneville M; Tiollier J; Romagné F
J Immunol; 2005 Oct; 175(8):5471-80. PubMed ID: 16210655
[TBL] [Abstract][Full Text] [Related]
11. CD70-CD27 interactions provide survival and proliferative signals that regulate T cell receptor-driven activation of human γδ peripheral blood lymphocytes.
DeBarros A; Chaves-Ferreira M; d'Orey F; Ribot JC; Silva-Santos B
Eur J Immunol; 2011 Jan; 41(1):195-201. PubMed ID: 21182090
[TBL] [Abstract][Full Text] [Related]
12. CRTAM receptor engagement by Necl-2 on tumor cells triggers cell death of activated Vγ9Vδ2 T cells.
Dessarthe B; Thedrez A; Latouche JB; Cabillic F; Drouet A; Daniel P; de La Pintière CT; Catros V; Toutirais O
J Immunol; 2013 May; 190(9):4868-76. PubMed ID: 23530148
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.
Lesport E; Baudhuin J; Sousa S; LeMaoult J; Zamborlini A; Rouas-Freiss N; Carosella ED; Favier B
Cell Mol Life Sci; 2011 Oct; 68(20):3385-99. PubMed ID: 21337044
[TBL] [Abstract][Full Text] [Related]
14. Vγ9Vδ2 T cell activation by strongly agonistic nucleotidic phosphoantigens.
Moulin M; Alguacil J; Gu S; Mehtougui A; Adams EJ; Peyrottes S; Champagne E
Cell Mol Life Sci; 2017 Dec; 74(23):4353-4367. PubMed ID: 28669030
[TBL] [Abstract][Full Text] [Related]
15. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors.
Halary F; Peyrat MA; Champagne E; Lopez-Botet M; Moretta A; Moretta L; Vié H; Fournié JJ; Bonneville M
Eur J Immunol; 1997 Nov; 27(11):2812-21. PubMed ID: 9394804
[TBL] [Abstract][Full Text] [Related]
16. HIV infection of monocytes-derived dendritic cells inhibits Vγ9Vδ2 T cells functions.
Sacchi A; Rinaldi A; Tumino N; Casetti R; Agrati C; Turchi F; Bordoni V; Cimini E; Martini F
PLoS One; 2014; 9(10):e111095. PubMed ID: 25340508
[TBL] [Abstract][Full Text] [Related]
17. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
Thedrez A; Harly C; Morice A; Salot S; Bonneville M; Scotet E
J Immunol; 2009 Mar; 182(6):3423-31. PubMed ID: 19265120
[TBL] [Abstract][Full Text] [Related]
18. Role of NKG2D and its ligands in the anti-infectious activity of Vγ9Vδ2 T cells against intracellular bacteria.
Bessoles S; Ni M; Garcia-Jimenez S; Sanchez F; Lafont V
Eur J Immunol; 2011 Jun; 41(6):1619-28. PubMed ID: 21469127
[TBL] [Abstract][Full Text] [Related]
19. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
[TBL] [Abstract][Full Text] [Related]
20. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M
Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
